Stephen V. Liu, MD
Stephen V. Liu, MD, is a thoracic medical oncologist and an Associate Professor of Medicine at Georgetown University. He is the Director of Thoracic Oncology and the Head of Developmental Therapeutics at the Georgetown University Lombardi Comprehensive Cancer Center. He is also co-host of the official IASLC podcast, Lung Cancer Considered.
Articles by Stephen V. Liu, MD
In the final segment of the roundtable discussion, the panel reflects on pressing unanswered questions in lung cancer.
In the fourth segment of this roundtable discussion, the panel weighs in on the most pressing unmet needs in NSCLC.
In the third segment of this roundtable discussion, the panel discusses considerations for community oncologists.
In the second segment of this roundtable discussion, the panel discusses the molecular testing landscape in NSCLC.
In the first segment of this roundtable discussion, the panel explores the rising incidence of young-onset lung cancer.
Dr. Liu discusses the implications of the accelerated approval and what the future may hold.
Dr. Liu explains how these two studies are shaping standards of care and the treatment landscape in SCLC.
The forum covered critical updates in the fields of NSCLC, SCLC, immunotherapy effectiveness, and recent trial updates.
The panel discussed advancements in the field, including results from a study of lurbinectedin plus atezolizumab for SCLC.
Sanjay Juneja, MD, with experts Dr. Liu, Dr. Das, and Dr. Singhi, answered major questions about oncology referrals in NSCLC.
Sanjay Juneja, MD, with experts Dr. Liu, Dr. Das, and Dr. Singhi, answered major questions about recent NSCLC innovations.
Sanjay Juneja, MD, directed a discussion with Dr. Liu, Dr. Das, and Dr. Singhi on key updates in the field of NSCLC.
Dr. Liu weighs in on the CheckMate 816 data presented at the 2025 ASCO Annual Meeting.
Stephen Liu, MD, shares his insights on the recent approval, the data behind it, and what the future may hold.
Stephen V. Liu, MD, shares what he sees as the key upcoming highlights in thoracic oncology at the ASCO Annual Meeting.
Dr. Liu discusses his experience as co-chair of the Texas Lung Cancer Conference and shares key highlights.
Dr. Liu discusses key data and updates in EGFR-positive NSCLC from the European Lung Cancer Congress.
Stephen V. Liu, MD, weighs in on the data from the preplanned interim analysis that was recently published in The Lancet.
Dr. Liu shares what he's looking forward to during the European Lung Cancer Congress, which will be held March 26-29.
Dr. Liu unpacks key questions in the field, and the research that could address them.
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.